Approvals/TGA/BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial

Approved

STANDARD

BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 977bf31fdd0bfac2
Product Name: BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial
Artg Id: 347291
Artg Name: BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2021-11-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/752239e879f9d14f7027b1f364fdb149.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

977bf31fdd0bfac2

Type

Standard